Release of Draft (Step 2) International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance: M4E(R2)

Notice to the reader:

The online consultation is now closed.

The above referenced draft guidance was released by the ICH Steering Committee for consultation and is being posted on the ICH website for information and comment in accordance with Step 2 of the ICH process.

How to Get Involved

This consultation is open for comment starting August 19, 2015 until November 17, 2015. Please select and read through the link below titled "consultation document". Once read, please submit your comments via email, fax or by mail to:

Kader Kourad
Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics
Biologics and Genetic Therapies Directorate
Health Products and Food Branch
Health Canada
100 Eglantine Driveway, Tunney's Pasture
Ottawa, Ontario
K1A 0K9

Email: kader.kourad@hc-sc.gc.ca
Telephone: 613-793-6103
Fax: 613-946-0639

Interested parties are encouraged to provide comments and suggestions by November 17, 2015.

Reporting to Canadians

Health Canada will make the results of this consultation available on this Web site.

If you have any questions, contact Kader Kourad.

Page details

Date modified: